Sarcomas are one of the principal groups of rare cancers in Europe. They represent 1% of all cancers and 2% of all cancer-related deaths. Sarcomas have some of the worst outcomes of all cancers. They pose challenges to our health care systems because they are often diagnosed at a late stage and are not well known among the public and healthcare professionals, as they appear in nearly 70 different types. The event will include addresses by EU Health Commissioner Andriukaitis, Professor Paolo Casali in his capacity as Coordinator of the Joint Action on Rare Cancers (JARC), and Dr Peter Naredi as President of the European CanCer Organisation (ECCO).
The following topics will be discussed:
• Hear the perspectives of key stakeholders on how to reduce the burden of sarcoma in Europe and discuss ongoing initiatives
• Hear about the policy recommendations of the Group of Experts on how to advance the policy response to sarcomas across Europe
• Discuss what steps can be taken at the European and national level to implement these recommendations